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For nearly 30 years, we have known 
that basal keratinocytes in the skin vary 
in their capacity to proliferate and that 
some of these cells have characteristics 
of epidermal stem cells (Bickenbach, 
1981; Lavker and Sun, 2000), whereas 
others have features common to multi-
potent stem cells (Liang and Bickenbach, 
2002). However, we still have no specific 
markers for these cells, only markers that 
enrich for them. Thus, recognizing the 
epidermal stem cell in a sea of non–stem 
cells remains problematic. Only after 
submitting a pool of epidermal cells to 
functional analysis can we say, “Aha, we 
had stem cells in that pool.” Because of 
this, determining the absolute numbers 
of cells in either the epidermal stem cell 
population or the transit-amplifying (TA) 
cell population continues to elude us. 
Various assays have suggested that 
anywhere from 1 in 10 to 1 in several 
thousand skin keratinocytes may function 
as stem cells. Some of the earliest of 
these assessments focused on positional 
analysis of the proliferating cells that are 
responsible for maintaining the structural 
epidermal proliferative unit in mouse epi-
dermis (Mackenzie, 1970; Potten, 1974). 
Both Mackenzie and Potten observed 
that in the epidermis, the basal cells 
beneath the edges of the large overlying 
hexagonal corneocytes are highly prolif-
erative, whereas the few basal cells that 
are centrally located are less proliferative. 
From this, they inferred that the central 
basal cells in the epidermal prolifera-
tive units are the epidermal stem cells. In 
this scenario, around 10% of the basal 
cells in mouse epidermis would be stem 
cells. Later assays using viral methods 
to permanently mark human keratino-
cytes before using them to recapitulate 
epidermal tissues demonstrated that in 
human skin, the epidermal proliferative 
unit may encompass more area and more 
TA cells (Ghazizadeh and Taichman, 
2005). Calculations of the number of 
these repopulating cells suggested that 
human epidermal stem cells represented 
less than 1% of the basal keratinocyte 
population. This number was consistent 
with that found in an in vitro organotypic 
culture, where less than 1% of the human 
basal keratinocytes could be identified 
as label-retaining cells (Muffler et al., 
2008). Moreover, when human basal 
keratinocytes were used to recapitulate 
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an epidermis in three-dimensional 
organotypic culture, the label-retaining 
cells were distributed sparsely along the 
basement membrane as single cells, sug-
gesting that a single epidermal stem cell 
maintains a large number of TA cells and 
a large area of the epidermis. Using a lim-
iting dilution in vivo assay, Ghadially and 
colleagues elegantly demonstrated that 
only 1 in 10,000 mouse basal keratino-
cytes (0.01%) can recapitulate an epider-
mis and maintain it long term (Schneider 
et al., 2003). This number corresponds to 
our estimate of the number of multipotent 
stem cells in mouse epidermis, based on 
the ability of keratinocytes to implant into 
the mouse blastocyst and participate in 
the development of other types of tissues 
(Liang and Bickenbach, 2002).
More recent studies have considered 
the age of the cell and how it affects the 
number and functionality of epider-
mal stem cells. Early work had assumed 
that as epidermal stem cells aged, they 
decreased in number or changed their 
function, as is the case in other tissues. 
For example, the number of epithelial 
stem cells in the small intestine is gradual-
ly reduced with age (Martin et al., 1998), 
and the function of hemato poietic stem 
cells gradually changes over time, with 
the ratio of differentiated cells in the myel-
oid versus lymphoid lineage increasing 
(Rossi et al., 2005). However, epider-
mal stem cells turned out to be different. 
They did not appear to participate in the 
aging process as did other stem cells. 
When epidermal stem cells isolated from 
young adult mouse skin were compared 
with those from old adult mouse skin, 
no substantial differences were observed 
with respect to the number of stem cells, 
gene expression pattern, or telomere 
length (Giangreco et al., 2008; Stern and 
Bickenbach, 2007). Moreover, blastocyst 
implantation assays demon strated that 
multipotency does not change with aging 
(Liang et al., 2004; Stern and Bickenbach, 
2007).
Perhaps this is not so surprising. 
Although our skin thins as it ages and 
may not heal as quickly as it did when 
it was young, it does heal, and it does 
maintain barrier properties well into old 
age (Webb and Kaur, 2006). If it did not, 
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we would die. Notably, skin grafts from 
older individuals can essentially outlive 
the donor (Gallico et al., 1984; Pellegrini 
et al., 1999). Thus, the epidermis can 
maintain a functional physiology well 
into old age. It is common knowledge 
that the epidermis sloughs a layer of cells 
every day, creating an enormous demand 
for replacement cells (Halprin, 1972). It 
has always been assumed that this need 
is met by stem cell proliferation followed 
by expansion of the TA-cell population. 
Given that epidermal functionality must 
be maintained throughout life, it was tac-
itly understood that the epidermal stem 
cells remained functional as long as the 
organism lived and that this cell popula-
tion met the continual demand for new 
cells. Studies in mouse skin confirmed 
that epidermal stem cells remain func-
tional and appear to resist cellular aging 
(Stern and Bickenbach, 2007). However, 
they did not assess the functionality of 
TA cells during aging. The article by 
Charruyer et al. in this issue addresses this 
question and demonstrates that it is the 
TA-cell population whose functionality 
changes as skin ages and that this change 
maintains the integrity of the epidermis in 
old mice.
In their study, Charruyer and colleagues 
measured the temporal longevity of 
replicating units using green fluorescent 
protein (GFP)-labeled epidermal cells in 
an in vivo transplantation assay instead 
of relying on secondary markers to dif-
ferentiate between what they refer to as 
“long-term” and “short-term” replicating 
units (RUs). They reasoned that if a RU 
was generated from a GFP-tagged stem 
cell, then it would persist long term, as 
evidenced by an island of GFP-producing 
daughter cells, whereas if the RU was 
generated by a TA cell, then the island 
of GFP-producing cells would disappear 
as the cells terminally differentiate and 
are sloughed from the epidermis. These 
investigators defined long-term RUs as 
those that survived longer than 9 weeks 
and short-term RUs as those that were 
lost before 9 weeks. In counting the num-
ber of RUs in keratinocytes originating 
from aged versus young mice over sev-
eral weeks, the authors made two primary 
observations. First, the number of long-
term RUs derived from old keratinocytes 
versus young keratinocytes did not differ 
significantly, indicating that the number 
of stem cells in aged and young epidermis 
is relatively constant. Second, although 
there were similar numbers of RUs from 
young and old keratinocytes 3 weeks after 
transplantation, at 5 weeks there were 
significantly fewer RUs produced by the 
young cell population than by the old cell 
population. Because no significant differ-
ence was detected in the number of long-
term RUs, the difference in the number 
of short-term RUs had to be due to the 
presence of fewer TA cells in the young 
epidermis. This presented a conundrum. 
One possible explanation is that the aged 
TA cells persist longer because they prog-
ress through the cell cycle more slowly 
than do the young TA cells. This idea is 
consistent with the researchers' findings 
that a larger fraction of aged epidermal 
cells were actively cycling, yet fewer cells 
were actually in the S-phase of the cell 
cycle. Although this explanation seems 
counterintuitive, it can be understood 
if one envisions a scenario of vehicles 
traveling on a crowded freeway at a set 
speed. If the speed is reduced, then the 
vehicles slow down, resulting in all vehi-
cles spending more time to complete their 
journeys—the overall outcome is more 
vehicles on the road at any given time or, 
in this case, more TA cells present in the 
aged epidermis.
Aside from the overall number of TA 
cells and their rates of proliferation, a 
third factor must also be considered in 
determining how rapidly differentiating 
epidermal cells can be replaced in aged 
epidermis: the cellular output (in terms 
of functional keratinocytes that can be 
generated) of a single TA cell. Charruyer 
et al. (2009) counted the cells in clusters 
derived from single cells and found that 
aged cells had a significantly decreased 
cellular output. When combined with 
their findings that the number of stem 
cells is relatively constant in aged and 
young keratinocyte populations and 
that the proliferative rate in aged cells is 
reduced, a new model begins to emerge: 
although the number of long-term RUs is 
similar in young versus aged epidermis, 
aging skin heals more slowly because of 
a reduction in the efficiency of regenera-
tion from TA cells.
The paper by Charruyer et al. 
represents a significant step in our 
understanding of regeneration of aging 
epidermis. They have demonstrated that 
the slow rate of healing in aged skin is 
probably due to previously unrecog nized 
changes in TA-cell kinetics, leading to a 
decrease in the cellular output of TA cells, 
a decrease in the rate of TA-cell prolifera-
tion, and (most unexpectedly) an overall 
increase in the number of functional TA 
cells in aged epidermis. Such change 
in TA-cell kinetics may be a means of 
compensating for general anomalies that 
accumulate with age, thereby maintain-
ing the epidermal barrier—which is criti-
cal to life—throughout old age.
Finally, the article by Charruyer et al. 
(2009) alters our understanding of the 
cellular niche in which the stem and TA 
cells reside. Using label retention as a 
marker for epidermal stem cells, Muffler 
et al. (2008) demonstrated that the micro-
environment is essential for both the sur-
vival and the function of stem cells; if the 
microenvironment were insufficiently 
maintained, long-term tissue regenera-
tion could not be achieved. Charruyer 
and co-workers take this one step fur-
ther, demonstrating that old epidermal 
stem cells placed into a young experi-
mental environment perform as well as 
their younger counterparts, whereas old 
TA cells change their kinetics. However, 
until the response of young epidermal 
stem cells and young TA cells to an old 
environment is tested, the question of 
which is more important to epidermal 
maintenance—cell-intrinsic characteris-
tics or environmental influences—cannot 
be fully answered.
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A New Way to Classify  
Genetic Skin Disease
Celia Moss1
Genetic disorders with skin manifestations often affect other organs as well, and 
diseases with a similar array of features might be linked pathogenetically. Classifying 
disorders by individual phenotypic components may reveal clusters with a common 
genetic cause and elucidate pathogenic links. If components are categorized inade-
quately, however, the method will simply confirm what is known, obscure true links, 
and suggest false ones.
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In this issue, Feramisco and colleagues 
identify 688 genetic skin disorders with 
both a characteristic cutaneous phe-
notype and a distinct molecular basis. 
The number of known genodermatoses 
has risen linearly since 1991, when 
about 90 such disorders were cataloged 
(Moss, 1991), through 2006, when we 
tabulated 580 such diseases (Leech and 
Moss, 2007). As the number of known 
genodermatoses increases, it becomes 
both more necessary and more rewarding 
to organize this information. Clinicians 
want catalogs they can search for a diag-
nosis; biologists need precise clinical 
descriptors to make sense of molecular 
information; and new patterns emerge 
as we arrange the mosaic fragments. 
Feramisco and colleagues present a sys-
tem of describing genodermatoses in 
terms of their individual cutaneous and 
systemic features in order to explore their 
relationships with one another and with 
genes and molecular pathways.
nosology of skin disease
Dermatologists have long sought to clas-
sify skin disorders. In the eighteenth and 
early nineteenth centuries, Joseph Plenck 
of Vienna, the Edinburgh physicians 
Robert Willan and Thomas Bateman, 
the Parisian Louis Marc Alibert, and the 
American Noah Worcester categorized 
dermatoses according to lesion type, 
inspired by the Linnaean system for 
plants (Connor, 2004). By the mid-nine-
teenth century, a better understanding 
of etiology facilitated pathological clas-
sification, led by Ferdinand Hebra of 
Vienna, and this is reflected in the chap-
ter headings of many standard dermatol-
ogy textbooks. Meanwhile, politicians 
and reformers were also taking an inter-
est in nosology; the first International List 
of Causes of Death, issued in 1900, was 
the forerunner of the 1989 International 
Classification of Diseases (ICD10), which 
is still in use (see “Web Resources”). 
Detailed though it is, the ICD10 does not 
meet the needs of dermatologists, and the 
British Association of Dermatologists has 
developed its own comprehensive diag-
nostic and procedural dictionaries with a 
clinically logical hierarchy of terms, more 
detailed than, but still mapped to, the 
ICD10 (see “Web Resources”).
Feramisco et al. (2009, this issue) use 
the classification and disease descrip-
tions of the geneticist Victor McKusick 
(1921–2008), who in 1966 published 
the first catalog of known genetic traits, 
Mendelian Inheritance in Man; 40 years 
later, he was still contributing to the online 
version, OMIM (see “Web Resources”). 
The distinctive tomes can still be seen 
on dermatologists’ bookshelves; for me, 
the silver ninth edition was a significant 
acquisition. McKusick’s classification is 
admirably simple: a broad split by mode 
of inheritance and, within that, alpha-
betical listings. The clinical features are 
described succinctly and authoritatively, 
together with genes and allelic variants. 
OMIM is part of the National Center for 
Biotechnology Information Entrez sys-
tem, which provides a massive informa-
tion base, linking, for example, clinical 
descriptions (OMIM) with genes, proteins, 
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